AstraZeneca Boosts Its COVID-19 Research with More Help From the Public Sector
Pharmaceutical companies and government agencies working together is an increasingly common theme in the search for effective COVID-19 treatments. On Tuesday, AstraZeneca (NYSE: AZN) licensed coronavirus-neutralizing antibodies from Vanderbilt University, and signed agreements with two U.S. federal agencies that will help test and manufacture them.
Vanderbilt's COVID-19 research effort is in turn funded by four U.S. government agencies through dozens of sub-agencies and institutes, among them the Defense Advanced Research Projects Agency (DARPA) and the Biomedical Advanced Research and Development Authority (BARDA).
Image source: Getty Images.
Source Fool.com
